Clarity Pharmaceuticals

Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company developing next-generation theranostic products for cancer treatment. Their proprietary SAR Technology platform utilizes copper isotopes for both imaging and therapy, addressing current limitations in the radiopharmaceutical sector. The company's pipeline includes products targeting prostate cancer, breast cancer, and neuroendocrine tumors. Clarity is headquartered in Sydney, Australia.

• Biotech